161 results on '"Dávalos, A"'
Search Results
2. Comparison of Three Scores of Collateral Status for Their Association With Clinical Outcome: The HERMES Collaboration.
3. Significance of Baseline Ischemic Core Volume on Stroke Outcome After Endovascular Therapy in Patients Age ≥75 Years: A Pooled Analysis of Individual Patient Data From 7 Trials.
4. Comparison of Three Scores of Collateral Status for Their Association With Clinical Outcome: The HERMES Collaboration.
5. Endovascular Treatment Effect Diminishes With Increasing Thrombus Perviousness: Pooled Data From 7 Trials on Acute Ischemic Stroke.
6. Prediction of Outcome and Endovascular Treatment Benefit: Validation and Update of the MR PREDICTS Decision Tool.
7. D-Dimer as Predictor of Large Vessel Occlusion in Acute Ischemic Stroke.
8. Computed Tomography Perfusion-Based Machine Learning Model Better Predicts Follow-Up Infarction in Patients With Acute Ischemic Stroke.
9. Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome.
10. Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice.
11. Stroke Risk Analysis, a System With a High Detection Rate of Atrial Fibrillation in Stroke and Transient Ischemic Attack.
12. Confirmatory Study of Time-Dependent Computed Tomographic Perfusion Thresholds for Use in Acute Ischemic Stroke.
13. Does Sex Modify the Effect of Endovascular Treatment for Ischemic Stroke?
14. Vessel Patency at 24 Hours and Its Relationship With Clinical Outcomes and Infarct Volume in REVASCAT Trial (Randomized Trial of Revascularization With Solitaire FR Device Versus Best Medical Therapy in the Treatment of Acute Stroke Due to Anterior...
15. Retrospective multicenter study of Solitaire FR for revascularization in the treatment of acute ischemic stroke.
16. Outcomes of intravenous thrombolysis after dissemination of the stroke code and designation of new referral hospitals in Catalonia: the Catalan Stroke Code and Thrombolysis (Cat-SCT) Monitored Study.
17. Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: how well are we correcting it?: implications for outcome.
18. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study.
19. The prognostic value of capillary glucose levels in acute stroke: the GLycemia in Acute Stroke (GLIAS) study.
20. The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men.
21. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA.
22. Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection.
23. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).
24. The metabolic syndrome and stroke: potential treatment approaches.
25. The prediction of malignant cerebral infarction by molecular brain barrier disruption markers.
26. Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.
27. Intracranial Carotid Artery Calcification Relates to Recanalization and Clinical Outcome After Mechanical Thrombectomy.
28. Desmoteplase 3 to 9 Hours After Major Artery Occlusion Stroke.
29. Access to Endovascular Treatment in Remote Areas: Analysis of the Reperfusion Treatment Registry of Catalonia.
30. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials.
31. Dynamic Magnetic Resonance Angiography Provides Collateral Circulation and Hemodynamic Information in Acute Ischemic Stroke.
32. Mechanical Thrombectomy in and Outside the REVASCAT Trial: Insights From a Concurrent Population-Based Stroke Registry.
33. Phone and Video-Based Modalities of Central Blinded Adjudication of Modified Rankin Scores in an Endovascular Stroke Trial.
34. State of acute endovascular therapy: report from the 12th thrombolysis, thrombectomy, and acute stroke therapy conference.
35. Outcomes of a Contemporary Cohort of 536 Consecutive Patients With Acute Ischemic Stroke Treated With Endovascular Therapy.
36. Design and validation of a prehospital stroke scale to predict large arterial occlusion: the rapid arterial occlusion evaluation scale.
37. Within-day and weekly variations of thrombolysis in acute ischemic stroke: results from safe implementation of treatments in stroke-international stroke thrombolysis register.
38. Design and Validation of a Prehospital Stroke Scale to Predict Large Arterial Occlusion The Rapid Arterial Occlusion Evaluation Scale.
39. Biological signatures of asymptomatic extra- and intracranial atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study.
40. Smoking Cessation 1 Year Poststroke and Damage to the Insular Cortex.
41. Early Biomarkers of Clinical-Diffusion Mismatch in Acute Ischemic Stroke.
42. Iron-related brain damage in patients with intracerebral hemorrhage.
43. Plasma beta-amyloid 1-40 is associated with the diffuse small vessel disease subtype.
44. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).
45. Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study.
46. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.
47. Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke.
48. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies.
49. Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke.
50. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.